Determination of 2,3-benzodiazepine derivatives in rat plasma by high-performance liquid chromatography

J Chromatogr A. 1999 Jun 18;846(1-2):165-8. doi: 10.1016/s0021-9673(99)00011-4.

Abstract

A simple high-performance liquid chromatographic method with ultraviolet detection at 240 nm for determination of a novel AMPA/kainate antagonist 1-(4'-aminophenyl)-3,5-dihydro-7,8-dimethoxy-2,3-benzodiazepine (2,3-BZ 6), and its derivatives in rat plasma is described. The procedure involves a fast extraction of the drugs from the plasma spiked with an internal standard. The samples are applied to a pre-packed glass column and drugs are eluted using ethyl acetate. A linear response was observed over the examined concentration range. The lower limit of detection of 2,3-BZ 6 was 5.5 ng/ml. The assay has been used to determine the time course of plasma levels of the 2,3-benzodiazepine derivatives in Sprague-Dawley rats.

MeSH terms

  • Animals
  • Benzodiazepines / blood*
  • Benzodiazepines / pharmacokinetics
  • Chromatography, High Pressure Liquid / methods*
  • Excitatory Amino Acid Antagonists / blood*
  • Excitatory Amino Acid Antagonists / pharmacokinetics
  • Rats
  • Rats, Sprague-Dawley
  • Reference Standards
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Spectrophotometry, Ultraviolet

Substances

  • 1-(4'-aminophenyl)-3,5-dihydro-7,8--dimethoxy-2,3-benzodiazepine
  • Excitatory Amino Acid Antagonists
  • Benzodiazepines